A single-center, retrospective cohort study analysing venetoclax in relapsed/refractory multiple myeloma
Latest Information Update: 10 May 2021
At a glance
- Drugs Venetoclax (Primary) ; Proteasome inhibitors
- Indications Multiple myeloma
- Focus Adverse reactions; Therapeutic Use
- 10 May 2021 New trial record